Telemetry Investments’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Telemetry Investments’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$593K	Hold	59,561	–	–	1.39%	27
2022 Q3	$581K	Hold	59,561	–	–	0.95%	42
2022 Q2	$578K	Hold	59,561	–	–	0.88%	42
2022 Q1	$578K	Buy	59,561 +5,900	+11%	+$57.2K	0.92%	41
2021 Q4	$518K	Sell	53,661 -400	-0.7%	-$3.89K	0.68%	50
2021 Q3	$524K	Buy	+54,061	New	+$527K	0.72%	46

Other funds holding NKGN

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Cubist Systematic Strategies Stamford, Connecticut $7.09B AUM 21.48% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return